Regarding trial NCT06122870 my opinion only.
The trial outcome will give a very early indication of the compounds efficacy 9very small cohort), I may be wrong but for my memory the only early data received re. efficacy against Campylobacter was via western blot analysis back in early 2017.
So the short answer is no, I don't believe the Campylobacter trial outcomes would cause the curtains to come down on the DoD collaborations. But thanks for the question , happy to hear others opinions.
- Forums
- ASX - By Stock
- Ann: Travelan to progress to Phase 3 Clinical Trials in the US
Regarding trial NCT06122870 my opinion only.The trial outcome...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMC (ASX) to my watchlist
|
|||||
Last
8.8¢ |
Change
0.002(2.33%) |
Mkt cap ! $20.06M |
Open | High | Low | Value | Volume |
8.6¢ | 8.8¢ | 8.6¢ | $7.336K | 83.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11900 | 8.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 19230 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11900 | 0.084 |
2 | 24690 | 0.081 |
2 | 59888 | 0.080 |
3 | 42004 | 0.079 |
2 | 41000 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 3100 | 1 |
0.094 | 164287 | 1 |
0.095 | 70000 | 1 |
0.100 | 5000 | 1 |
0.105 | 21190 | 2 |
Last trade - 13.59pm 05/07/2024 (20 minute delay) ? |
Featured News
IMC (ASX) Chart |